Literature DB >> 34492688

Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve Monitoring.

Jack Chang1,2,3,4, Jiajun Liu1,2,3,4, Keith S Kaye5, Marc H Scheetz1,2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34492688      PMCID： PMC8423459          DOI： 10.1093/cid/ciaa1849

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  10 in total

1.  Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Jennifer Le; Thomas P Lodise; Donald P Levine; John S Bradley; Catherine Liu; Bruce A Mueller; Manjunath P Pai; Annie Wong-Beringer; John C Rotschafer; Keith A Rodvold; Holly D Maples; Benjamin M Lomaestro
Journal:  Am J Health Syst Pharm       Date:  2020-05-19       Impact factor: 2.637

2.  Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.

Authors:  Gwendolyn M Pais; Sean N Avedissian; J Nicholas O'Donnell; Nathaniel J Rhodes; Thomas P Lodise; Walter C Prozialeck; Peter C Lamar; Cameron Cluff; Anil Gulati; Julie C Fitzgerald; Kevin J Downes; Athena F Zuppa; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

3.  Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.

Authors:  Sean N Avedissian; Gwendolyn M Pais; J Nicholas O'Donnell; Thomas P Lodise; Jiajun Liu; Walter C Prozialeck; Medha D Joshi; Peter C Lamar; Leighton Becher; Anil Gulati; William Hope; Marc H Scheetz
Journal:  J Antimicrob Chemother       Date:  2019-08-01       Impact factor: 5.790

4.  Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

Authors:  Thomas P Lodise; Nimish Patel; Ben M Lomaestro; Keith A Rodvold; George L Drusano
Journal:  Clin Infect Dis       Date:  2009-08-15       Impact factor: 9.079

5.  Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.

Authors:  Steven Y C Tong; David C Lye; Dafna Yahav; Archana Sud; J Owen Robinson; Jane Nelson; Sophia Archuleta; Matthew A Roberts; Alan Cass; David L Paterson; Hong Foo; Mical Paul; Stephen D Guy; Adrian R Tramontana; Genevieve B Walls; Stephen McBride; Narin Bak; Niladri Ghosh; Benjamin A Rogers; Anna P Ralph; Jane Davies; Patricia E Ferguson; Ravindra Dotel; Genevieve L McKew; Timothy J Gray; Natasha E Holmes; Simon Smith; Morgyn S Warner; Shirin Kalimuddin; Barnaby E Young; Naomi Runnegar; David N Andresen; Nicholas A Anagnostou; Sandra A Johnson; Mark D Chatfield; Allen C Cheng; Vance G Fowler; Benjamin P Howden; Niamh Meagher; David J Price; Sebastiaan J van Hal; Matthew V N O'Sullivan; Joshua S Davis
Journal:  JAMA       Date:  2020-02-11       Impact factor: 56.272

6.  Vancomycin Advanced Therapeutic Drug Monitoring: Exercise in Futility or Virtuous Endeavor to Improve Drug Efficacy and Safety?

Authors:  Thomas J Dilworth; Lucas T Schulz; Warren E Rose
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

7.  The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications.

Authors:  Diane M Parente; Cheston B Cunha; Eleftherios Mylonakis; Tristan T Timbrook
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

Review 8.  Vancomycin-Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention.

Authors:  Gwendolyn M Pais; Jiajun Liu; Sanja Zepcan; Sean N Avedissian; Nathaniel J Rhodes; Kevin J Downes; Ganesh S Moorthy; Marc H Scheetz
Journal:  Pharmacotherapy       Date:  2020-05-04       Impact factor: 4.705

9.  The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE).

Authors:  Thomas P Lodise; Susan L Rosenkranz; Matthew Finnemeyer; Scott Evans; Matthew Sims; Marcus J Zervos; C Buddy Creech; Pratish C Patel; Michael Keefer; Paul Riska; Fernanda P Silveira; Marc Scheetz; Richard G Wunderink; Martin Rodriguez; John Schrank; Susan C Bleasdale; Sara Schultz; Michelle Barron; Ann Stapleton; Dannah Wray; Henry Chambers; Vance G Fowler; Thomas L Holland
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

10.  Vancomycin Exposure and Acute Kidney Injury Outcome: A Snapshot From the CAMERA2 Study.

Authors:  Jiajun Liu; Steven Y C Tong; Joshua S Davis; Nathaniel J Rhodes; Marc H Scheetz
Journal:  Open Forum Infect Dis       Date:  2020-11-04       Impact factor: 3.835
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.